Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder? | Zendy

Yvette E. Lentferink | Zendy; E.M.W. van de Garde | Zendy; Catherijne A. J. Knibbe | Zendy; Marja M. J. van der Vorst | Zendy

Open Access

Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder?

Author(s) -

Yvette E. Lentferink,

E.M.W. van de Garde,

Catherijne A. J. Knibbe,

Marja M. J. van der Vorst

Publication year - 2018

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2017.0163

Subject(s) - underweight , overweight , body mass index , methylphenidate , medicine , attention deficit hyperactivity disorder , obesity , pediatrics , population , cohort , psychiatry , environmental health

Attention-deficit/hyperactivity disorder (ADHD) is often treated with psychostimulants. Psychostimulants' adverse effects on body mass index standard deviation score (BMI-sds) and height in children/adolescents with ADHD have been reported. However, literature is inconsistent, and it is unclear whether the observed effects are dosage- and/or BMI-dependent. Therefore, the aim of this retrospective observational study is to evaluate the influence of psychostimulants on BMI-sds and height-sds in a pediatric cohort with ADHD from an outpatient clinic, and to study the correlation between psychostimulant dosage and BMI-sds and height-sds change.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research